|
PRPF40A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.916200E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.393500E-04 |
| Normal-vs-Stage2 |
3.227800E-01 |
| Normal-vs-Stage3 |
8.024200E-01 |
| Normal-vs-Stage4 |
6.706000E-01 |
| Stage1-vs-Stage2 |
5.664400E-01 |
| Stage1-vs-Stage3 |
9.292500E-02 |
| Stage1-vs-Stage4 |
4.245800E-01 |
| Stage2-vs-Stage3 |
5.074600E-01 |
| Stage2-vs-Stage4 |
7.869600E-01 |
| Stage3-vs-Stage4 |
8.033200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.938900E-03 |
| Normal-vs-AfricanAmerican |
5.802100E-02 |
| Normal-vs-Asian |
9.587400E-01 |
| Caucasian-vs-AfricanAmerican |
9.086000E-01 |
| Caucasian-vs-Asian |
5.107800E-01 |
| AfricanAmerican-vs-Asian |
5.487200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.74869999999872E-05 |
| Normal-vs-Female |
3.032800E-01 |
| Male-vs-Female |
1.209030E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.056000E-02 |
| Normal-vs-Extreme_Weight |
6.18740000013496E-07 |
| Normal-vs-Obese |
4.905600E-01 |
| Normal-vs-Extreme_Obese |
1.659650E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.696850E-01 |
| Normal_Weight-vs-Obese |
2.455600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.917400E-01 |
| Extreme_Weight-vs-Obese |
5.382600E-03 |
| Extreme_Weight-vs-Extreme_Obese |
4.536000E-01 |
| Obese-vs-Extreme_Obese |
4.369600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.137400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.348580E-01 |
| Normal-vs-Age(61-80Yrs) |
2.802100E-04 |
| Normal-vs-Age(81-100Yrs) |
9.401600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.667500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.495600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.331620E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.147600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.153700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.068000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.70770000000165E-05 |
| Normal-VS-Type2 PRCC |
1.223360E-01 |
| Normal-VS-KIRP CIMP |
7.140400E-02 |
| Normal-VS-Unclassified PRCC |
9.622600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.924800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.496390E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.008400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.198000E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.211400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.088200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.632500E-04 |
| Normal-vs-N1 |
1.163160E-01 |
| Normal-vs-N2 |
8.350000E-01 |
| N0-vs-N1 |
3.556500E-03 |
| N0-vs-N2 |
1.687000E-01 |
| N1-vs-N2 |
6.419400E-01 |
|
|
